Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06552130 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Importance of Insulin Action in the Brain for the Immune System During Physical Activity

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment target: 36 to 20v7
  2. Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 20 to confirmed 36
    • Primary completion date changed from estimate of Aug 2026 to Aug 14, 2025
    • Site details revised
    v6
  3. Re-verified, no change to tracked fieldsv5
  4. Secondary endpoints: details revised at 6 of 7 entries
    • Study description revised
    v4
  5. Start date: Aug 15, 2024 to Dec 15, 2024
    • Secondary endpoints: 6 to 7
    v3
  6. Trial status: Not Yet Recruiting to Recruiting
    • Start date: Aug 2024 to Aug 15, 2024
    • Site details revised
    v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to clarify the interaction of central insulin action and physical activity with the immune system. Therefore, participants will undergo bicycle spiroergometer tests. This approach will be compared between days with insulin delivery to the brain as nasal spray and days with placebo spray.
Trial Details
NCT Number NCT06552130
Lead Sponsor University of Ulm
Conditions
(from sponsor)		 Insulin Sensitivity
Related terms Insulin Resistance, Motor Activity
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov